{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:39Z","timestamp":1791270159471,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurologic.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ncl.2014.09.012","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T06:16:45Z","timestamp":1416982605000},"page":"39-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Atypical Parkinsonism"],"prefix":"10.1016","volume":"33","author":[{"given":"Maria","family":"Stamelou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2014.09.012_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2990.1989.tb01147.x","article-title":"The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease","volume":"15","author":"Gibb","year":"1989","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ncl.2014.09.012_bib2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.25509","article-title":"\u201cAtypical\u201d atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide","volume":"28","author":"Stamelou","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/mds.23062","article-title":"Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease","volume":"25","author":"Josephs","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000052991.70149.68","article-title":"Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study","volume":"60","author":"Nath","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2009.08.036","article-title":"Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy","volume":"289","author":"Kertesz","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study","volume":"60","author":"Litvan","year":"1996","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mds.24992","article-title":"Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases","volume":"27","author":"Stamelou","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.WNL.0000072325.27824.A5","article-title":"Tau exon 10\u00a0+16 mutation FTDP-17 presenting clinically as sporadic young onset PSP","volume":"61","author":"Morris","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archneur.65.4.460","article-title":"Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN)","volume":"65","author":"Boeve","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy","volume":"43","author":"Hoglinger","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2014.09.012_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/jcbfm.2009.2","article-title":"In\u00a0vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy","volume":"29","author":"Stamelou","year":"2009","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2014.09.012_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/120.1.65","article-title":"Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study","volume":"120","author":"Litvan","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.10680","article-title":"Accuracy of clinical diagnosis of progressive supranuclear palsy","volume":"19","author":"Osaki","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnbeh.2012.00088","article-title":"Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease","volume":"6","author":"Marx","year":"2012","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.ncl.2014.09.012_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-7091-6641-3_6","article-title":"Cognitive disturbances in progressive supranuclear palsy","volume":"42","author":"Litvan","year":"1994","journal-title":"J\u00a0Neural Transm Suppl"},{"key":"10.1016\/j.ncl.2014.09.012_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13554790590962933","article-title":"Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing","volume":"11","author":"Paviour","year":"2005","journal-title":"Neurocase"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.012_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mds.25327","article-title":"Accuracy of the National Institute for Neurological Disorders and Stroke\/Society for Progressive Supranuclear Palsy and Neuroprotection and Natural History in Parkinson Plus Syndromes Criteria for the Diagnosis of Progressive Supranuclear Palsy","volume":"28","author":"Respondek","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib24","first-page":"549","article-title":"Magnetic resonance imaging in progressive supranuclear palsy","volume":"258","author":"Stamelou","year":"2011","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease","volume":"26","author":"Longoni","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib26","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/mds.22090","article-title":"Applause sign in parkinsonian disorders and Huntington\u2019s disease","volume":"23","author":"Wu","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/mds.24968","article-title":"Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy","volume":"27","author":"Massey","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","article-title":"Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes","volume":"59","author":"Vlaar","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"Alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/WCO.0b013e3283632da6","article-title":"Atypical parkinsonism: an update","volume":"26","author":"Stamelou","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S1474-4422(14)70088-2","article-title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2\/3 trial","volume":"13","author":"Boxer","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib34","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/brain\/awq115","article-title":"Rational therapeutic approaches to progressive supranuclear palsy","volume":"133","author":"Stamelou","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial","volume":"23","author":"Stamelou","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"Hoglinger","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A\u00a0phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib38","first-page":"5","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study","volume":"257","author":"Colosimo","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib39","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/brain\/awr234","article-title":"Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome","volume":"134","author":"Kouri","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S1041610209008862","article-title":"Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy","volume":"21","author":"Borroni","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib42","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mds.25113","article-title":"Cognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature","volume":"27","author":"Lee","year":"2012","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.012_bib43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp-2012-303618","article-title":"The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders","volume":"84","author":"Rittman","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib44","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21055","article-title":"Alzheimer's disease presenting as corticobasal syndrome","volume":"21","author":"Chand","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1586\/ern.11.153","article-title":"The corticobasal syndrome-Alzheimer's disease conundrum","volume":"11","author":"Hassan","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ncl.2014.09.012_bib46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.54.3.697","article-title":"Differentiation of atypical parkinsonian syndromes with routine MRI","volume":"54","author":"Schrag","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib47","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","article-title":"[18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism","volume":"79","author":"Hellwig","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.012_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00234-012-1132-7","article-title":"Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography","volume":"55","author":"Tripathi","year":"2013","journal-title":"Neuroradiology"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2014.09.012_bib49","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/mds.25685","article-title":"The COQ2 mutations in Japanese multiple system atrophy: impact on the pathogenesis and phenotypic variation","volume":"29","author":"Ozawa","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2 in familial and sporadic multiple-system atrophy","volume":"369","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2014.09.012_bib53","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.parkreldis.2013.05.004","article-title":"Markedly asymmetric presentation in multiple system atrophy","volume":"19","author":"Batla","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 4","key":"10.1016\/j.ncl.2014.09.012_bib54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib55","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jnnp-2011-301068","article-title":"Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests","volume":"83","author":"Iodice","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib57","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/mds.22187","article-title":"Autonomic dysfunction in different subtypes of multiple system atrophy","volume":"23","author":"Schmidt","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2012.02.023","article-title":"The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy","volume":"317","author":"Kimpinski","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib60","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000196638.98781.bb","article-title":"Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease","volume":"66","author":"Benarroch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1600-0404.1995.tb00414.x","article-title":"Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease\u2013a retrospective comparison","volume":"91","author":"Magalhaes","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2014.09.012_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","article-title":"Multiple system atrophy: a review of 203 pathologically proven cases","volume":"12","author":"Wenning","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib63","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.40.4.677","article-title":"Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure","volume":"40","author":"Munschauer","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02317801","article-title":"Assessment of cardiovascular autonomic dysfunction in multiple system atrophy","volume":"11","author":"Kitae","year":"2001","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.ncl.2014.09.012_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/jnnp.64.5.683","article-title":"REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure","volume":"64","author":"Plazzi","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib66","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.clinph.2007.08.014","article-title":"Impaired cortical and autonomic arousal during sleep in multiple system atrophy","volume":"118","author":"Vetrugno","year":"2007","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.012_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1750-3639.2012.00637.x","article-title":"Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease","volume":"23","author":"Ahmed","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ncl.2014.09.012_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/01.WNL.0000073745.68744.94","article-title":"REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA","volume":"61","author":"Gilman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","article-title":"Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD","volume":"65","author":"Iranzo","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib70","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.48.4.1094","article-title":"REM sleep behavior disorders in multiple system atrophy","volume":"48","author":"Plazzi","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp.58.3.379-a","article-title":"REM sleep behaviour disorder as the presenting symptom of multiple system atrophy","volume":"58","author":"Tison","year":"1995","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ncl.2014.09.012_bib72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology","volume":"8","author":"Gilman","year":"1998","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.ncl.2014.09.012_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.parkreldis.2008.08.001","article-title":"Differences in skin sympathetic involvements between two chronic autonomic disorders: multiple system atrophy and pure autonomic failure","volume":"15","author":"Asahina","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib74","first-page":"72","article-title":"Differences in overshoot of blood pressure after head-up tilt in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy","volume":"252","author":"Asahina","year":"2005","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2013.10.039","article-title":"Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy","volume":"336","author":"Brisinda","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib76","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.clineuro.2007.07.020","article-title":"Assessment of autonomic dysfunction of multiple system atrophy with laryngeal abductor paralysis as an early manifestation","volume":"109","author":"Deguchi","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ncl.2014.09.012_bib77","first-page":"263","article-title":"Hot cross bun sign in a patient with SCA-2","volume":"92","author":"Marrannes","year":"2009","journal-title":"JBR-BTR"},{"key":"10.1016\/j.ncl.2014.09.012_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2012.11.009","article-title":"Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy","volume":"325","author":"Han","year":"2013","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2377-12-39","article-title":"Hyperintense putaminal rim at 1.5 T: prevalence in normal subjects and distinguishing features from multiple system atrophy","volume":"12","author":"Tha","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib80","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2014.09.012_bib81","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/mds.25948","article-title":"Flt3 ligand does not differentiate between Parkinsonian disorders","volume":"29","author":"Silajdzic","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","article-title":"The neuropathology, pathophysiology and genetics of multiple system atrophy","volume":"38","author":"Ahmed","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ncl.2014.09.012_bib83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1750-3639.1999.tb00553.x","article-title":"Multiple system atrophy: a sporadic synucleinopathy","volume":"9","author":"Dickson","year":"1999","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.012_bib84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib85","first-page":"1182","article-title":"A\u00a0randomized, placebo-controlled clinical trial to assess the effects of rasagiline in patients with multiple system atrophy of the parkinsonian subtype","volume":"27","author":"Poewe","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib86","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(13)70301-6","article-title":"Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial","volume":"13","author":"Low","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2377-12-131","article-title":"Treatment of multiple system atrophy using intravenous immunoglobulin","volume":"12","author":"Novak","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A\u00a0randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib89","doi-asserted-by":"crossref","DOI":"10.1007\/s10286-014-0249-7","article-title":"Novel therapeutic approaches in multiple system atrophy","author":"Palma","year":"2014","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.ncl.2014.09.012_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000086754","article-title":"Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors","volume":"54","author":"Papapetropoulos","year":"2005","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib91","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mds.10347","article-title":"Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome","volume":"18","author":"Weeks","year":"2003","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.012_bib92","first-page":"1031","article-title":"MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy","volume":"260","author":"Petrovic","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib93","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/awl347","article-title":"Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?","volume":"130","author":"Lannuzel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib94","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/mds.23200","article-title":"Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes","volume":"25","author":"Gilbert","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.012_bib95","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3233\/JAD-2012-120445","article-title":"Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG","volume":"32","author":"Kasahata","year":"2012","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ncl.2014.09.012_bib96","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/brain\/awg231","article-title":"Neurofilament inclusion body disease: a new proteinopathy?","volume":"126","author":"Josephs","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-007-0329-z","article-title":"Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study","volume":"115","author":"Yokota","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2014.09.012_bib98","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/mds.21645","article-title":"Primary lateral sclerosis mimicking atypical parkinsonism","volume":"22","author":"Norlinah","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib99","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/NRL.0b013e31815b0de2","article-title":"Frontal-subcortical dementias","volume":"14","author":"Bonelli","year":"2008","journal-title":"Neurologist"},{"key":"10.1016\/j.ncl.2014.09.012_bib100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000326907","article-title":"Midbrain atrophy in vascular Parkinsonism","volume":"65","author":"Choi","year":"2011","journal-title":"Eur Neurol"},{"issue":"Pt 3","key":"10.1016\/j.ncl.2014.09.012_bib101","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/brain\/118.3.759","article-title":"The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal","volume":"118","author":"Daniel","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.09.012_bib102","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.parkreldis.2011.05.016","article-title":"Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy","volume":"17","author":"Favaretto","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib103","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/01.WNL.0000115170.40838.9B","article-title":"Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm","volume":"62","author":"Mokri","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib104","first-page":"169","article-title":"Corticobasal degeneration look-alikes","volume":"82","author":"Bhatia","year":"2000","journal-title":"Adv Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1752-1947-5-357","article-title":"A\u00a064-year old man presenting with carotid artery occlusion and corticobasal syndrome: a case report","volume":"5","author":"Engelen","year":"2011","journal-title":"J\u00a0Med Case Rep"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.012_bib106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1750-3639.2012.00611.x","article-title":"Etiologies of parkinsonism in a century-long autopsy-based cohort","volume":"23","author":"Horvath","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ncl.2014.09.012_bib107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MD.0b013e3181f204a8","article-title":"Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center","volume":"89","author":"Lagier","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ncl.2014.09.012_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.05.029","article-title":"Isolated intracranial Whipple's disease\u2013report of a rare case and review of the literature","volume":"308","author":"Mohamed","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib109","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/1531-8257(200007)15:4<730::AID-MDS1020>3.0.CO;2-O","article-title":"Neurosyphilis presenting as progressive supranuclear palsy","volume":"15","author":"Murialdo","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp.45.1.86","article-title":"Vertical supranuclear gaze palsy with secondary syphilis","volume":"45","author":"Page","year":"1982","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.012_bib111","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10072-011-0875-y","article-title":"Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection","volume":"33","author":"Jang","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2014.09.012_bib112","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/mds.20221","article-title":"Neurosyphilis masquerading as corticobasal degeneration","volume":"19","author":"Benito-Leon","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib113","first-page":"242","article-title":"A\u00a0\u201ccortico-basal degeneration\u201d-like syndrome as first sign of progressive multifocal leukoencephalopathy","volume":"100","author":"Van Zanducke","year":"2000","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.ncl.2014.09.012_bib114","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneurol.2011.56","article-title":"Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma","volume":"68","author":"Adams","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncpneuro0287","article-title":"Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease","volume":"2","author":"Castle","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.ncl.2014.09.012_bib116","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/WNL.35.3.446-a","article-title":"Progressive supranuclear palsy: paraneoplastic effect of bronchial carcinoma","volume":"35","author":"Jankovic","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.012_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.parkreldis.2004.09.003","article-title":"Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma","volume":"11","author":"Tan","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"10.1016\/j.ncl.2014.09.012_bib118","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/mds.25239","article-title":"Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus","volume":"27","author":"Peeters","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib119","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mds.870040309","article-title":"Cerebral sarcoidosis presenting as supranuclear gaze palsy with hypokinetic rigid syndrome","volume":"4","author":"Schlegel","year":"1989","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib120","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.20842","article-title":"Atypical movement disorders in antiphospholipid syndrome","volume":"21","author":"Martino","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2014.09.012_bib121","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/1531-8257(199905)14:3<530::AID-MDS1030>3.0.CO;2-8","article-title":"Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome","volume":"14","author":"Morris","year":"1999","journal-title":"Mov Disord"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T20:53:59Z","timestamp":1566075239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861914000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0733861914000802"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2014.09.012","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical Parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2014.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}